139 related articles for article (PubMed ID: 28992489)
21. The in vitro effects of piroxicam and meloxicam on canine cell lines.
Knottenbelt C; Chambers G; Gault E; Argyle DJ
J Small Anim Pract; 2006 Jan; 47(1):14-20. PubMed ID: 16417605
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle kinetics of uninfected and feline leukemia virus-infected canine lymphoma cell lines: effects of methotrexate treatment.
Torres J; Klein RM; Tung HN; Chapman AL
Virchows Arch B Cell Pathol Incl Mol Pathol; 1980; 33(2):139-53. PubMed ID: 6109397
[TBL] [Abstract][Full Text] [Related]
23. Anticancer effects of high-dose ascorbate on canine melanoma cell lines.
Shin H; Nam A; Song KH; Lee K; Rebhun RB; Seo KW
Vet Comp Oncol; 2018 Dec; 16(4):616-621. PubMed ID: 30188000
[TBL] [Abstract][Full Text] [Related]
24. Soy-derived isoflavones inhibit the growth of canine lymphoid cell lines.
Jamadar-Shroff V; Papich MG; Suter SE
Clin Cancer Res; 2009 Feb; 15(4):1269-76. PubMed ID: 19228730
[TBL] [Abstract][Full Text] [Related]
25. Mushroom-derived maitake PETfraction as single agent for the treatment of lymphoma in dogs.
Griessmayr PC; Gauthier M; Barber LG; Cotter SM
J Vet Intern Med; 2007; 21(6):1409-12. PubMed ID: 18196755
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 2-methoxyestradiol and methotrexate effects on non-Hodgkin's B-cell lymphoma.
Park J; Franco RS; Augsburger JJ; Banerjee RK
Curr Eye Res; 2007; 32(7-8):659-67. PubMed ID: 17852190
[TBL] [Abstract][Full Text] [Related]
27. Assessment of Y chromosome copy number alterations in non-neoplastic and neoplastic leukocytes of male dogs.
Mochizuki H; Estrada AJ; Boggess M
Vet J; 2024 Apr; 304():106088. PubMed ID: 38412887
[TBL] [Abstract][Full Text] [Related]
28. Novel acyclic nucleotide analogues GS-343074 and GS-424044 demonstrate antiproliferative and pro-apoptotic activity in canine neoplastic cell lines.
Lawrence JA; Huelsmeyer MK; Thamm DH; Tumas DB; Birkus G; Kurzman I; Vail DM
Vet Comp Oncol; 2015 Sep; 13(3):246-54. PubMed ID: 23672437
[TBL] [Abstract][Full Text] [Related]
29. Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.
Wells JW; Evans CH; Scott MC; Rütgen BC; O'Brien TD; Modiano JF; Cvetkovic G; Tepic S
PLoS One; 2013; 8(1):e54464. PubMed ID: 23365669
[TBL] [Abstract][Full Text] [Related]
30. An Antibody Specific for the Dog Leukocyte Antigen DR (DLA-DR) and Its Novel Methotrexate Conjugate Inhibit the Growth of Canine B Cell Lymphoma.
Lisowska M; Milczarek M; Ciekot J; Kutkowska J; Hildebrand W; Rapak A; Miazek A
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31561563
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitin-specific protease 7 as a potential therapeutic target in dogs with hematopoietic malignancies.
Pawlak A; Bajzert J; Bugiel K; Hernández Suárez B; Kutkowska J; Rapak A; Hildebrand W; Obmińska-Mrukowicz B; Freire R; Smits VAJ
J Vet Intern Med; 2021 Mar; 35(2):1041-1051. PubMed ID: 33650720
[TBL] [Abstract][Full Text] [Related]
32. High-dose methotrexate is lethal to rats. Why give it to children?
Cole PD; Kamen BA
Pediatr Hematol Oncol; 2000 Dec; 17(8):609-13. PubMed ID: 11127392
[No Abstract] [Full Text] [Related]
33. Metal-free salan-type compound induces apoptosis and overcomes multidrug resistance in leukemic and lymphoma cells in vitro.
Dragoun M; Günther T; Frias C; Berkessel A; Prokop A
J Cancer Res Clin Oncol; 2018 Apr; 144(4):685-695. PubMed ID: 29374786
[TBL] [Abstract][Full Text] [Related]
34. The oncolytic effects of reovirus in canine solid tumor cell lines.
Igase M; Hwang CC; Coffey M; Okuda M; Noguchi S; Mizuno T
J Vet Med Sci; 2015 May; 77(5):541-8. PubMed ID: 25648933
[TBL] [Abstract][Full Text] [Related]
35. Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines.
Herman S; Zurgil N; Deutsch M
Inflamm Res; 2005 Jul; 54(7):273-80. PubMed ID: 16134056
[TBL] [Abstract][Full Text] [Related]
36. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
37. Development of multidrug resistance in a canine lymphoma cell line.
Uozurmi K; Nakaichi M; Yamamoto Y; Une S; Taura Y
Res Vet Sci; 2005 Jun; 78(3):217-24. PubMed ID: 15766940
[TBL] [Abstract][Full Text] [Related]
38. A potential therapeutic application of SET/I2PP2A inhibitor OP449 for canine T-cell lymphoma.
Fujiwara N; Kawasaki H; Yabe R; Christensen DJ; Vitek MP; Mizuno T; Sato K; Ohama T
J Vet Med Sci; 2013; 75(3):349-54. PubMed ID: 23131782
[TBL] [Abstract][Full Text] [Related]
39. Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma.
Tsurusawa M; Gosho M; Mori T; Mitsui T; Sunami S; Kobayashi R; Fukano R; Tanaka F; Fujita N; Inada H; Koh K; Takimoto T; Saito A; Fujimoto J; Nakazawa A; Horibe K;
Pediatr Blood Cancer; 2015 Feb; 62(2):279-284. PubMed ID: 25359701
[TBL] [Abstract][Full Text] [Related]
40. DNMT1: an emerging target in the treatment of invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Hahn NM; Waddell J; Olbricht GR; Zheng R; Stewart JC; Knapp DW
Urol Oncol; 2013 Nov; 31(8):1761-9. PubMed ID: 22609058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
